HNFSA

Hanover Foods Corporation HNFSA

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode HNFSA IRCKF BFNH CFOO NGTF MBAIF LNLHF INBP DTEAF GLGLF
6M -11.45 % 27.59 % 33.33 % 0.00 % 165.96 % -15.12 % 0.00 % -8.01 % -16.00 % -95.54 %
YTD -23.00 % 27.59 % -10.41 % -13.78 % 624.64 % 52.17 % 0.00 % -3.08 % 48.17 % -95.54 %
1Y -28.57 % 27.59 % -36.71 % -13.78 % 596.86 % 294.37 % 0.00 % -1.56 % 93.19 % -95.54 %
3Y -9.49 % 85.00 % -80.00 % -73.44 % -58.33 % -89.42 % -56.90 % -27.91 % -10.00 % -98.96 %
5Y -39.20 % 140.57 % 33.33 % -51.18 % -52.11 % -91.86 % -94.17 % -61.68 % -80.43 % -99.63 %
10Y -48.72 % 18 400.00 % 700.00 % -34.27 % -97.28 % -77.30 % -95.45 % 244.44 % -94.90 % -99.63 %
From the beginning -19.64 % 3 310.14 % -4.00 % -66.81 % -94.12 % -97.79 % -95.45 % -94.40 % -97.67 % -99.99 %

Dividend

Hanover Foods Corporation

Integrated BioPharma, Inc.